Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis Inês Leonor Leitão; Carla Mimoso Santos; Paulo André; Sara Lino; Marcos Lemos; Filipe Froes;

Evolution of the antimicrobial resistance rates in clinical isolates of Pseudomonas aeruginosa causing invasive infections in the south of Spain Felipe Fernández-Cuenca; Luis Martínez-Martínez; Álvaro Pascual;

Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa Lorena López-Cerero; Sofia Ballesta; Cristina Elías López; Waldo Sánchez-Yebra; María Dolores Rojo-Martin; Alvaro Pascual;